These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15003512)

  • 1. Purification, identification, and characterization of elastase on erythrocyte membrane as factor IX-activating enzyme.
    Iwata H; Kaibara M; Dohmae N; Takio K; Himeno R; Kawakami S
    Biochem Biophys Res Commun; 2004 Mar; 316(1):65-70. PubMed ID: 15003512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of factor IX by erythrocyte membranes causes intrinsic coagulation.
    Iwata H; Kaibara M
    Blood Coagul Fibrinolysis; 2002 Sep; 13(6):489-96. PubMed ID: 12192300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheological approach to the analysis of blood coagulation in endothelial cell-coated tubes: activation of the intrinsic reaction on the erythrocyte surface.
    Kawakami S; Kaibara M; Kawamoto Y; Yamanaka K
    Biorheology; 1995; 32(5):521-36. PubMed ID: 8541522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil elastase cleavage of human factor IX generates an activated factor IX-like product devoid of coagulant function.
    Samis JA; Kam E; Nesheim ME; Giles AR
    Blood; 1998 Aug; 92(4):1287-96. PubMed ID: 9694717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of canine factor IX.
    Sugahara Y; Catalfamo J; Brooks M; Hitomi E; Bajaj SP; Kurachi K
    Thromb Haemost; 1996 Mar; 75(3):450-5. PubMed ID: 8701406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.
    Manno CS; Pierce GF; Arruda VR; Glader B; Ragni M; Rasko JJ; Ozelo MC; Hoots K; Blatt P; Konkle B; Dake M; Kaye R; Razavi M; Zajko A; Zehnder J; Rustagi PK; Nakai H; Chew A; Leonard D; Wright JF; Lessard RR; Sommer JM; Tigges M; Sabatino D; Luk A; Jiang H; Mingozzi F; Couto L; Ertl HC; High KA; Kay MA
    Nat Med; 2006 Mar; 12(3):342-7. PubMed ID: 16474400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor IX activation by factor XIa proceeds without release of a free intermediate.
    Wolberg AS; Morris DP; Stafford DW
    Biochemistry; 1997 Apr; 36(14):4074-9. PubMed ID: 9100000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biochemical mechanism of blood coagulation (author's transl)].
    Maki M
    Rinsho Byori; 1981 Jan; 29(1):1-10. PubMed ID: 7289094
    [No Abstract]   [Full Text] [Related]  

  • 9. Top-down characterization of protein pharmaceuticals by liquid chromatography/mass spectrometry: application to recombinant factor IX comparability- a case study.
    Rouse JC; McClellan JE; Patel HK; Jankowski MA; Porter TJ
    Methods Mol Biol; 2005; 308():435-60. PubMed ID: 16082054
    [No Abstract]   [Full Text] [Related]  

  • 10. The quality of plasma collected by automated apheresis and of recovered plasma from leukodepleted whole blood.
    Runkel S; Haubelt H; Hitzler W; Hellstern P
    Transfusion; 2005 Mar; 45(3):427-32. PubMed ID: 15752162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheological analyses of coagulation of blood from different individuals with special reference to procoagulant activity of erythrocytes.
    Kaibara M; Iwata H; Ujiie H; Himeno R; Kaibara M
    Blood Coagul Fibrinolysis; 2005 Jul; 16(5):355-63. PubMed ID: 15970720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence and structural properties of identical mutations with varying phenotypes in human coagulation factor IX.
    Chavali S; Sharma A; Tabassum R; Bharadwaj D
    Proteins; 2008 Oct; 73(1):63-71. PubMed ID: 18393396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of human erythrocyte glyceraldehyde-3-phosphate dehydrogenase by ferriprotoporphyrin IX.
    Omodeo Salè F; Vanzulli E; Caielli S; Taramelli D
    FEBS Lett; 2005 Sep; 579(22):5095-9. PubMed ID: 16139273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystallization of an anti-factor IX antibody and its complex.
    Shi X; Li Y; Bian C; Zhao G; Huang M
    Acta Crystallogr D Biol Crystallogr; 2005 Jun; 61(Pt 6):701-3. PubMed ID: 15930624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme kinetics and characterization of mouse pancreatic elastase.
    Nadarajah D; Atkinson MA; Huebner P; Starcher B
    Connect Tissue Res; 2008; 49(6):409-15. PubMed ID: 19085241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of seminal factor IX and factor IXa in fertile, nonfertile, and vasectomy subjects: a step closer toward identifying a functional clotting system in human semen.
    Lwaleed BA; Greenfield RS; Hicks J; Birch BR; Cooper AJ
    J Androl; 2005; 26(1):146-52. PubMed ID: 15611579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning, sequencing, and analysis of the full-length CDNA of rhesus monkey factor IX.
    Ding Y; Wang J; Tan W; Chen Y; Lu X; Lu Y; Li S; Li H; Wang L; Cheng J
    Transplant Proc; 2008 Oct; 40(8):2769-72. PubMed ID: 18929857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A C-type lectin-like protein from Agkistrodon acutus venom binds to both platelet glycoprotein Ib and coagulation factor IX/factor X.
    Li WF; Chen L; Li XM; Liu J
    Biochem Biophys Res Commun; 2005 Jul; 332(3):904-12. PubMed ID: 15925567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Fmoc-amino acid carrying an unmasked carbohydrate to the synthesis of the epidermal growth factor-like domain of bovine blood coagulation factor IX.
    Takemura T; Hojo H; Nakahara Y; Ishimizu T; Hase S
    Org Biomol Chem; 2004 Jan; 2(1):133-6. PubMed ID: 14737672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XIa dimer in the activation of factor IX.
    Sinha D; Marcinkiewicz M; Lear JD; Walsh PN
    Biochemistry; 2005 Aug; 44(30):10416-22. PubMed ID: 16042419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.